PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction

Background Immune checkpoint inhibitors (ICIs) have been an important therapeutic advancement in the field of cancer medicine. Recent reports provided greater insights into the cardiovascular adverse events, which prohibited the use of ICIs. Cardiovascular adverse events occur in different forms, su...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenzheng Xia, Hanbin Chen, Didi Chen, Yijia Ye, Congying Xie, Meng Hou
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001293.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846172615149879296
author Wenzheng Xia
Hanbin Chen
Didi Chen
Yijia Ye
Congying Xie
Meng Hou
author_facet Wenzheng Xia
Hanbin Chen
Didi Chen
Yijia Ye
Congying Xie
Meng Hou
author_sort Wenzheng Xia
collection DOAJ
description Background Immune checkpoint inhibitors (ICIs) have been an important therapeutic advancement in the field of cancer medicine. Recent reports provided greater insights into the cardiovascular adverse events, which prohibited the use of ICIs. Cardiovascular adverse events occur in different forms, such as myocarditis and cardiomyopathy, myocardial fibrosis, heart failure and pericardial disease. Cardiac aging overlapped with the occurrence of some cardiac diseases. Exosomes mediate cell–cell cross talk in cardiac diseases by transferring a variety of biomolecules, including microRNAs (miRs). miR-34a-5p is a well-known miR associated with the cardiac senescence. This study aimed to investigate whether cardiovascular adverse effects of the programmed cell death 1 (PD-1) inhibitor, a widely used ICI, were related to exosomal-transferred miR-34a-5p in cardiac senescence in a mouse model.Methods and results The upregulation of miR-34a-5p in cardiomyocytes induced by exosomes derived from PD-1 inhibitor–treated macrophages, accompanied by cardiac senescence, caused cardiac injury in mouse hearts. miR-34a-5p was identified as an exosomal transfer RNA to induce cardiac senescence–related injury. Inhibiting miR-34a-5p in macrophages attenuated the exosomePD-1 inhibitor-induced pro-senescent effect in cardiomyocytes. TargetScan and luciferase assay showed that miR-34a-5p targeted the serine/threonine-protein phosphatase 1 regulatory subunit 10 (PNUTS) 3′-untranslated region.Conclusions Exosomes derived from PD-1 inhibitor–treated macrophages exerted a pro-senescent effect by modulating the miR-34a-5p/PNUTS signaling pathway. The findings might supply new targets to ameliorate cardiac injury in patients with cancer receiving PD-1 inhibitor treatment.
format Article
id doaj-art-b401edf4f0af44d7ac2cba30b923f9d0
institution Kabale University
issn 2051-1426
language English
publishDate 2020-10-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-b401edf4f0af44d7ac2cba30b923f9d02024-11-09T21:20:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-10-018210.1136/jitc-2020-001293PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunctionWenzheng Xia0Hanbin Chen1Didi Chen2Yijia Ye3Congying Xie4Meng Hou51 Neurosurgery, Wenzhou Medical University First Affiliated Hospital, Wenzhou, Zhejiang, China2 Department of Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China3 Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China3 Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China3 Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China3 Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, ChinaBackground Immune checkpoint inhibitors (ICIs) have been an important therapeutic advancement in the field of cancer medicine. Recent reports provided greater insights into the cardiovascular adverse events, which prohibited the use of ICIs. Cardiovascular adverse events occur in different forms, such as myocarditis and cardiomyopathy, myocardial fibrosis, heart failure and pericardial disease. Cardiac aging overlapped with the occurrence of some cardiac diseases. Exosomes mediate cell–cell cross talk in cardiac diseases by transferring a variety of biomolecules, including microRNAs (miRs). miR-34a-5p is a well-known miR associated with the cardiac senescence. This study aimed to investigate whether cardiovascular adverse effects of the programmed cell death 1 (PD-1) inhibitor, a widely used ICI, were related to exosomal-transferred miR-34a-5p in cardiac senescence in a mouse model.Methods and results The upregulation of miR-34a-5p in cardiomyocytes induced by exosomes derived from PD-1 inhibitor–treated macrophages, accompanied by cardiac senescence, caused cardiac injury in mouse hearts. miR-34a-5p was identified as an exosomal transfer RNA to induce cardiac senescence–related injury. Inhibiting miR-34a-5p in macrophages attenuated the exosomePD-1 inhibitor-induced pro-senescent effect in cardiomyocytes. TargetScan and luciferase assay showed that miR-34a-5p targeted the serine/threonine-protein phosphatase 1 regulatory subunit 10 (PNUTS) 3′-untranslated region.Conclusions Exosomes derived from PD-1 inhibitor–treated macrophages exerted a pro-senescent effect by modulating the miR-34a-5p/PNUTS signaling pathway. The findings might supply new targets to ameliorate cardiac injury in patients with cancer receiving PD-1 inhibitor treatment.https://jitc.bmj.com/content/8/2/e001293.full
spellingShingle Wenzheng Xia
Hanbin Chen
Didi Chen
Yijia Ye
Congying Xie
Meng Hou
PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
Journal for ImmunoTherapy of Cancer
title PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
title_full PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
title_fullStr PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
title_full_unstemmed PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
title_short PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
title_sort pd 1 inhibitor inducing exosomal mir 34a 5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor related cardiac dysfunction
url https://jitc.bmj.com/content/8/2/e001293.full
work_keys_str_mv AT wenzhengxia pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction
AT hanbinchen pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction
AT didichen pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction
AT yijiaye pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction
AT congyingxie pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction
AT menghou pd1inhibitorinducingexosomalmir34a5pexpressionmediatesthecrosstalkbetweencardiomyocyteandmacrophageinimmunecheckpointinhibitorrelatedcardiacdysfunction